Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults

British Journal of Haematology

Volumn 158, Issue 5, 2012, Pages 615-625

  Omer, Bilal ^a,b,c   Kadan Lottick, Nina S ^a,b   Roberts, Kenneth B ^a,b   Wang, Rong ^a   Demsky, Carolyn ^a   Kupfer, Gary M ^a,b   Cooper, Dennis ^a,b   Seropian, Stuart ^a,b   Ma, Xiaomei ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Chemotherapy; Combined modality therapy; Hodgkin; Lymphoma; Radiotherapy; Second malignant neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE SULFATE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PATIENT ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RISK ASSESSMENT; SECOND CANCER; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY DOSAGE; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865148841     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09211.x     Document Type: Article

References (40)

1. Abrahamsen, J.F., Andersen, A., Hannisdal, E., Nome, O., Abrahamsen, A.F., Kvaløy, S. & Høst, H. (1993) Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age. Journal of Clinical Oncology, 11, 255-261.
2. Basu, S.K., Schwartz, C., Fisher, S.G., Hudson, M.M., Tarbell, N., Muhs, A., Marcus, K.J., Mendenhall, N., Mauch, P., Kun, L.E. & Constine, L.S. (2008) Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. International Journal of Radiation Oncology Biology Physics, 72, 34-40.
3. Bhatia, S., Yasui, Y., Robison, L.L., Birch, J.M., Bogue, M.K., Diller, L., DeLaat, C., Fossati-Bellani, F., Morgan, E., Oberlin, O., Reaman, G., Ruymann, F.B., Tersak, J. & Meadows, A.T. (2003) High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. Journal of Clinical Oncology, 21, 4386-4394.
4. Canellos, G.P., Anderson, J.R., Propert, K.J., Nissen, N., Cooper, M.R., Henderson, E.S., Green, M.R., Gottlieb, A. & Peterson, B.A. (1992) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. The New England Journal of Medicine, 327, 1478-1484.
5. Castellino, S.M., Geiger, A.M., Mertens, A.C., Leisenring, W.M., Tooze, J.A., Goodman, P., Stovall, M., Robison, L.L. & Hudson, M.M. (2011) Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood, 117, 1806-1816.
6. Chera, B.S., Rodriguez, C., Morris, C.G., Louis, D., Yeung, D., Li, Z. & Mendenhall, N.P. (2009) Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. International Journal of Radiation Oncology Biology Physics, 75, 1173-1180.
7. Chronowski, G.M., Wilder, R.B., Levy, L.B., Atkinson, E.N., Ha, C.S., Hagemeister, F.B., Barista, I., Rodriguez, M.A., Sarris, A.H., Hess, M.A., Cabanillas, F. & Cox, J.D. (2004) Second malignancies after chemotherapy and radiotherapy for Hodgkin disease. American Journal of Clinical Oncology, 27, 73-80.
8. Constine, L.S. (2008) Cured of Hodgkin Lymphoma, but suffering a broken heart. Leukemia and Lymphoma, 49, 1433-1435.
9. De Bruin, M.L., Sparidans, J., van't Veer, M.B., Noordijk, E.M., Louwman, M.W., Zijlstra, J.M., van den Berg, H., Russell, N.S., Broeks, A., Baaijens, M.H., Aleman, B.M. & van Leeuwen, F.E. (2009) Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. Journal of Clinical Oncology, 27, 4239-4246.
10. DeVita, Jr, V.T. (2003) Hodgkin's disease-clinical trials and travails. The New England Journal of Medicine, 348, 2375-2376.
11. Engert, A., Plutschow, A., Eich, H.T., Lohri, A., Dorken, B., Borchmann, P., Berger, B., Greil, R., Willborn, K.C., Wilhelm, M., Debus, J., Eble, M.J., Sokler, M., Ho, A., Rank, A., Ganser, A., Trumper, L., Bokemeyer, C., Kirchner, H., Schubert, J., Kral, Z., Fuchs, M., Muller-Hermelink, H.K., Muller, R.P. & Diehl, V. (2010) Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. The New England Journal of Medicine, 363, 640-652.
12. Favier, O., Heutte, N., Stamatoullas-Bastard, A., Carde, P., Van't Veer, M.B., Aleman, B.M., Noordijk, E.M., Thomas, J., Ferme, C. & Henry-Amar, M. (2009) Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials. Cancer, 115, 1680-1691.
13. Foss Abrahamsen, A., Andersen, A., Nome, O., Jacobsen, A.B., Holte, H., Foss Abrahamsen, J. & Kvaloy, S. (2002) Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time. Annals of Oncology, 13, 1786-1791.
14. Franklin, J., Pluetschow, A., Paus, M., Specht, L., Anselmo, A.P., Aviles, A., Biti, G., Bogatyreva, T., Bonadonna, G., Brillant, C., Cavalieri, E., Diehl, V., Eghbali, H., Fermé, C., Henry-Amar, M., Hoppe, R., Howard, S., Meyer, R., Niedzwiecki, D., Pavlovsky, S., Radford, J., Raemaekers, J., Ryder, D., Schiller, P., Shakhtarina, S., Valagussa, P., Wilimas, J. & Yahalom, J. (2006) Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Annals of Oncology, 17, 1749-1760.
15. Girinsky, T. & Ghalibafian, M. (2007) Radiotherapy of Hodgkin lymphoma: indications, new fields, and techniques. Seminars in Radiation Oncology, 17, 206-222.
16. Hodgson, D.C., Gilbert, E.S., Dores, G.M., Schonfeld, S.J., Lynch, C.F., Storm, H., Hall, P., Langmark, F., Pukkala, E., Andersson, M., Kaijser, M., Joensuu, H., Fossa, S.D. & Travis, L.B. (2007) Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. Journal of Clinical Oncology, 25, 1489-1497.
17. Hoppe, R.T. (1997) Hodgkin's disease: complications of therapy and excess mortality. Annals of Oncology, 8(Suppl 1), 115-118.
18. Inskip, P.D., Robison, L.L., Stovall, M., Smith, S.A., Hammond, S., Mertens, A.C., Whitton, J.A., Diller, L., Kenney, L., Donaldson, S.S., Meadows, A.T. & Neglia, J.P. (2009) Radiation dose and breast cancer risk in the childhood cancer survivor study. Journal of Clinical Oncology, 27, 3901-3907.
19. Koh, E.S., Tran, T.H., Heydarian, M., Sachs, R.K., Tsang, R.W., Brenner, D.J., Pintilie, M., Xu, T., Chung, J., Paul, N. & Hodgson, D.C. (2007) A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk. Radiation Oncology, 2, 13.
20. Koontz, B.F., Kirkpatrick, J.P., Clough, R.W., Prosnitz, R.G., Gockerman, J.P., Moore, J.O. & Prosnitz, L.R. (2006) Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications. Journal of Clinical Oncology, 24, 605-611.
21. Laskar, S., Gupta, T., Vimal, S., Muckaden, M.A., Saikia, T.K., Pai, S.K., Naresh, K.N. & Dinshaw, K.A. (2004) Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? Journal of Clinical Oncology, 22, 62-68.
22. Meadows, A.T., Friedman, D.L., Neglia, J.P., Mertens, A.C., Donaldson, S.S., Stovall, M., Hammond, S., Yasui, Y. & Inskip, P.D. (2009) Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. Journal of Clinical Oncology, 27, 2356-2362.
23. Meyer, R.M., Gospodarowicz, M.K., Connors, J.M., Pearcey, R.G., Bezjak, A., Wells, W.A., Burns, B.F., Winter, J.N., Horning, S.J., Dar, A.R., Djurfeldt, M.S., Ding, K. & Shepherd, L.E. (2005) Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. Journal of Clinical Oncology, 23, 4634-4642.
24. Meyer, R.M., Gospodarowicz, M.K., Connors, J.M., Pearcey, R.G., Wells, W.A., Winter, J.N., Horning, S.J., Dar, A.R., Shustik, C., Stewart, D.A., Crump, M., Djurfeldt, M.S., Chen, B.E. & Shepherd, L.E. (2011) ABVD Alone versus Radiation-Based therapy in Limited-Stage Hodgkin's lymphoma. The New England Journal of Medicine, 366, 399-408.
25. Nachman, J.B., Sposto, R., Herzog, P., Gilchrist, G.S., Wolden, S.L., Thomson, J., Kadin, M.E., Pattengale, P., Davis, P.C., Hutchinson, R.J. & White, K. (2002) Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. Journal of Clinical Oncology, 20, 3765-3771.
26. Ng, A.K., Bernardo, M.P., Weller, E., Backstrand, K.H., Silver, B., Marcus, K.C., Tarbell, N.J., Friedberg, J., Canellos, G.P. & Mauch, P.M. (2002a) Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. Journal of Clinical Oncology, 20, 2101-2108.
27. Ng, A.K., Bernardo, M.V., Weller, E., Backstrand, K., Silver, B., Marcus, K.C., Tarbell, N.J., Stevenson, M.A., Friedberg, J.W. & Mauch, P.M. (2002b) Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood, 100, 1989-1996.
28. Nishioka, T., Tsuchiya, K., Nishioka, S., Kitahara, T., Ohmori, K., Homma, A., Aoyma, H., Shindoh, M. & Shirato, H. (2004) Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck. International Journal of Radiation Oncology Biology Physics, 60, 847-852.
29. O'Brien, M.M., Donaldson, S.S., Balise, R.R., Whittemore, A.S. & Link, M.P. (2010) Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. Journal of Clinical Oncology, 28, 1232-1239.
30. Provencio, M., Espana, P., Millan, I., Sanchez, A., Cantos, B. & Bonilla, F. (2003) The management of stage I-II supradiaphragmatic Hodgkin's disease with chemotherapy alone. Leukemia and Lymphoma, 44, 263-268.
31. Salloum, E., Doria, R., Schubert, W., Zelterman, D., Holford, T., Roberts, K.B., Farber, L.R., Kiehl, R.K., Cardinale, J. & Cooper, D.L. (1996) Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. Journal of Clinical Oncology, 14, 2435-2443.
32. Straus, D.J. (2011) Chemotherapy alone for Early-Stage Hodgkin's lymphoma. The New England Journal of Medicine, 366, 470-471.
33. Straus, D.J., Portlock, C.S., Qin, J., Myers, J., Zelenetz, A.D., Moskowitz, C., Noy, A., Goy, A. & Yahalom, J. (2004) Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. Blood, 104, 3483-3489.
34. Swerdlow, A.J., Douglas, A.J., Hudson, G.V., Hudson, B.V., Bennett, M.H. & MacLennan, K.A. (1992) Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. British Medical Journal, 304, 1137-1143.
35. Travis, L.B., Gospodarowicz, M., Curtis, R.E., Clarke, E.A., Andersson, M., Glimelius, B., Joensuu, T., Lynch, C.F., van Leeuwen, F.E., Holowaty, E., Storm, H., Glimelius, I., Pukkala, E., Stovall, M., Fraumeni, Jr, J.F., Boice, Jr, J.D. & Gilbert, E. (2002) Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. Journal of the National Cancer Institute, 94, 182-192.
36. Travis, L.B., Hill, D., Dores, G.M., Gospodarowicz, M., van Leeuwen, F.E., Holowaty, E., Glimelius, B., Andersson, M., Pukkala, E., Lynch, C.F., Pee, D., Smith, S.A., Van't Veer, M.B., Joensuu, T., Storm, H., Stovall, M., Boice, Jr, J.D., Gilbert, E. & Gail, M.H. (2005) Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. Journal of the National Cancer Institute, 97, 1428-1437.
37. Tucker, M.A., Coleman, C.N., Cox, R.S., Varghese, A. & Rosenberg, S.A. (1988) Risk of second cancers after treatment for Hodgkin's disease. New England Journal of Medicine, 318, 76-81.
38. van Leeuwen, F.E., Klokman, W.J., Hagenbeek, A., Noyon, R., van den Belt-Dusebout, A.W., van Kerkhoff, E.H., van Heerde, P. & Somers, R. (1994) Second cancer risk following Hodgkin's disease: a 20-year follow-up study. Journal of Clinical Oncology, 12, 312-325.
39. Weber, D.C., Peguret, N., Dipasquale, G. & Cozzi, L. (2009) Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study. International Journal of Radiation Oncology Biology Physics, 75, 1578-1586.
40. Zittoun, R., Audebert, A., Hoerni, B., Bernadou, A., Krulik, M., Rojouan, J., Eghbali, H., Merle-Beral, H., Parlier, Y. & Diebold, J. (1985) Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease. Journal of Clinical Oncology, 3, 207-214.